Drug Profile

Doxepin low dose - Somaxon Pharmaceuticals

Alternative Names: Doxepin low dose; Silenor; SO-101

Latest Information Update: 27 Apr 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Somaxon Pharmaceuticals
Developer Endo, Inc.; Somaxon Pharmaceuticals
Class Antipruritics; Dibenzoxepins; Oxepins; Sleep disorder therapies; Small molecules; Tricyclic antidepressants
Mechanism of Action Histamine H1 receptor antagonists; Neurotransmitter uptake inhibitors; Serotonin uptake inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No
Available For Licensing Yes

Highest Development Phases

Marketed Insomnia

Most Recent Events

23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
18 Jun 2020 CJ HealthCare is now called HK inno.N
30 Apr 2019 Currax Pharmaceuticals acquired all the assets of Pernix Therapeutics ,

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com